A detailed history of Bridgeway Capital Management, LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 265,295 shares of PYXS stock, worth $448,348. This represents 0.02% of its overall portfolio holdings.

Number of Shares
265,295
Previous 246,495 7.63%
Holding current value
$448,348
Previous $815,000 19.39%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.83 - $3.94 $53,204 - $74,072
18,800 Added 7.63%
265,295 $973,000
Q2 2024

Aug 14, 2024

BUY
$3.06 - $5.58 $45,900 - $83,700
15,000 Added 6.48%
246,495 $815,000
Q1 2024

May 15, 2024

SELL
$2.03 - $6.59 $9,540 - $30,973
-4,700 Reduced 1.99%
231,495 $986,000
Q3 2023

Nov 14, 2023

SELL
$1.6 - $2.78 $80,000 - $139,000
-50,000 Reduced 17.47%
236,195 $470,000
Q2 2023

Aug 14, 2023

BUY
$2.46 - $4.07 $285,114 - $471,713
115,900 Added 68.06%
286,195 $732,000
Q4 2022

Feb 14, 2023

BUY
$1.14 - $2.0 $56,999 - $100,000
50,000 Added 41.56%
170,295 $228,000
Q3 2022

Nov 14, 2022

BUY
$1.88 - $3.03 $94,000 - $151,500
50,000 Added 71.13%
120,295 $237,000
Q2 2022

Aug 15, 2022

BUY
$2.02 - $4.53 $141,995 - $318,436
70,295 New
70,295 $167,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.